Synthesis and anticonvulsant activity of 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analogues

References

• White HS. Preclinical development of antiepileptic drugs: past, present, and future directions. Epilepsia 2003;44 Suppl 7:2–8.
   PubMed Web of Science ®Google Scholar
• Dimmock JR, Pandeya SN, Quail JW, Pugazhenthi U, Allen TM, Kao GY, Balzarini J, DeClereq E. Nicotinic acid hydrazone: a novel anticonvulsant pharmacophore. Eur J Med Chem 1995;30:303–314.
   Web of Science ®Google Scholar
• Duncan JS. The promise of new antiepileptic drugs. Br J Clin Pharmacol 2002;53:123–131.
   PubMed Web of Science ®Google Scholar
• Antiepileptic Drug and Device Trials XI Conference. (2011). CPP-115 for refractory complex partial seizures and infantile spasm. Aventura, FL, April 27–29.
   Google Scholar
• Budakoti A, Bhat AR, Athar F, Azam A. Syntheses and evaluation of 3-(3-bromo phenyl)-5-phenyl-1-(thiazolo [4,5-b] quinoxaline-2-yl)-2-pyrazoline derivatives. Eur J Med Chem 2008;43:1749–1757.
   PubMed Web of Science ®Google Scholar
• Parmar SS, Pandey BR, Dwivedi C, Harbison RD. Anticonvulsant activity and monoamine oxidase inhibitory properties of 1,3,5-trisubstituted pyrazolines. J Pharm Sci 1974;63:1152–1155.
   PubMed Web of Science ®Google Scholar
• Dawane BS, Konda SG, Mandawad GG, Shaikh BM. Poly(ethylene glycol) (PEG-400) as an alternative reaction solvent for the synthesis of some new 1-(4-(4′-chlorophenyl)-2-thiazolyl)-3-aryl-5-(2-butyl-4-chloro-1H-imidazol-5yl)-2-pyrazolines and their in vitro antimicrobial evaluation. Eur J Med Chem 2010;45:387–392.
   PubMed Web of Science ®Google Scholar
• Sharma PK, Kumar S, Kumar P, Kaushik P, Kaushik D, Dhingra Y et al. Synthesis and biological evaluation of some pyrazolylpyrazolines as anti-inflammatory-antimicrobial agents. Eur J Med Chem 2010;45:2650–2655.
   PubMed Web of Science ®Google Scholar
• Bilgin AA, Palaska E, Sunal R. Studies on the synthesis and antidepressant activity of some 1-thiocarbamoyl-3,5-diphenyl-2-pyrazolines. Arzneimittelforschung 1993;43:1041–1044.
   PubMed Web of Science ®Google Scholar
• Turan-Zitouni G, Chevallet P, Kiliç FS, Erol K. Synthesis of some thiazolyl-pyrazoline derivatives and preliminary investigation of their hypotensive activity. Eur J Med Chem 2000;35:635–641.
   PubMed Web of Science ®Google Scholar
• Mui MS, Siew BN, Buss AD, Crasta SC, Kah LG, Sue KL. Synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIV. Bioorg Med Chem Lett 2002;12:679–699.
   Google Scholar
• Manna F, Chimenti F, Fioravanti R, Bolasco A, Secci D, Chimenti P et al. Synthesis of some pyrazole derivatives and preliminary investigation of their affinity binding to P-glycoprotein. Bioorg Med Chem Lett 2005;15:4632–4635.
   PubMed Web of Science ®Google Scholar
• Ali MA, Shaharyar M, Siddiqui AA. Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives. Eur J Med Chem 2007;42:268–275.
   PubMed Web of Science ®Google Scholar
• Ahsan MJ, Samy JG, Dutt KR, Agrawal UK, Yadav BS, Vyas S et al. Design, synthesis and antimycobacterial evaluation of novel 3-substituted-N-aryl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide analogues. Bioorg Med Chem Lett 2011;21:4451–4453.
   PubMedGoogle Scholar
• Ahsan MJ, Samy JG, Soni S, Jain N, Kumar L, Sharma LK et al. Discovery of novel antitubercular 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analogues. Bioorg Med Chem Lett 2011;21:5259–5261.
   PubMedGoogle Scholar
• Ahsan MJ, Samy JG, Khalilullah H, Bakht MA, Hassan MZ. Synthesis and antimycobacterial evaluation of 3a,4-dihydro-3H-indeno [1,2-c] pyrazole-2-carboxamide analogues. Eur J Med Chem 2011;46:5694–5697.
   PubMedGoogle Scholar
• Amir M, Ahsan MJ, Ali I. Synthesis of N1-(3-chloro-4-fluorophenyl)-N4-substituted semicarbazones as novel anticonvulsant agents. Ind J Chem 2010;49B:1509–1514.
   Google Scholar
• Swinyard EA, Woodhead JH, White HS, Franklin MR. (1989). General principles: experimental selection, quantification, and evaluation of anticonvulsants. In: Levy RH,Mattson RH, Melmm B, Penry JK, Dreifuss FE, ed. Antiepileptic Drugs. New York: Raven Press, 85–102.
   Google Scholar
• White HS, Johnson M, Wolf HH, Kupferberg HJ. The early identification of anticonvulsant activity: role of the maximal electroshock and subcutaneous pentylenetetrazol seizure models. Ital J Neurol Sci 1995;16:73–77.
   PubMedGoogle Scholar
• White HS, Woodhead JH, Franklin MR. (1995). General principles: experimental selection, quantification, and evaluation of antiepileptic drugs. In: Levy RH,Mattson RH, Meldrum B, ed. Antiepileptic Drugs. New York: Raven Press, 99–110.
   Google Scholar
• DUNHAM NW, MIYA TS. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc (Baltim) 1957;46:208–209.
   PubMed Web of Science ®Google Scholar
• Barton ME, Klein BD, Wolf HH, White HS. Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy. Epilepsy Res 2001;47:217–227.
   PubMed Web of Science ®Google Scholar
• TOMAN JE, EVERETT GM, RICHARDS RK. The search for new drugs against epilepsy. Tex Rep Biol Med 1952;10:96–104.
   PubMedGoogle Scholar
• Noraberg J, Poulsen FR, Blaabjerg M, Kristensen BW, Bonde C, Montero M et al. Organotypic hippocampal slice cultures for studies of brain damage, neuroprotection and neurorepair. Curr Drug Targets CNS Neurol Disord 2005;4:435–452.
   PubMedGoogle Scholar
• Pandeya SN, Raja AS, Stables JP. Synthesis of isatin semicarbazones as novel anticonvulsants–role of hydrogen bonding. J Pharm Pharm Sci 2002;5:266–271.
   PubMed Web of Science ®Google Scholar